OncoDx Panel NGS Genetic DNA Test
Introduction
The OncoDx Panel NGS Genetic DNA Test is a state-of-the-art diagnostic tool designed to assess genetic predispositions to various types of cancer. Utilizing Next Generation Sequencing (NGS) technology, this test provides a comprehensive analysis of multiple genes associated with hereditary cancer syndromes. Understanding your genetic risk is essential for early detection, prevention, and personalized treatment strategies.
What the Test Measures
This test measures mutations in critical genes linked to cancer, including but not limited to: APC, ATM, BRCA1, BRCA2, CDH1, and TP53. By identifying these mutations, healthcare providers can evaluate the risk of developing specific cancers and recommend appropriate screening or preventive measures.
Who Should Consider This Test?
Individuals who may benefit from the OncoDx Panel NGS Genetic DNA Test include:
- Those with a family history of cancer, especially breast, ovarian, or colorectal cancers.
- Patients exhibiting symptoms associated with hereditary cancer syndromes.
- Individuals seeking personalized treatment options based on genetic makeup.
Benefits of Taking the Test
The OncoDx Panel NGS Genetic DNA Test offers several advantages:
- Early detection of cancer risk, allowing for proactive management.
- Informed decision-making regarding preventive measures and treatment options.
- Guidance for family members regarding their own cancer risks.
Understanding Your Results
Results from the OncoDx Panel NGS Genetic DNA Test will indicate whether any mutations were detected in the genes analyzed. A genetic counselor will help interpret these results, providing insights into potential cancer risks and the implications for you and your family.
Test Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
OncoDx Panel NGS Genetic DNA Test | 400,000 NGN | 600,000 NGN |
Book the Test
To schedule your OncoDx Panel NGS Genetic DNA Test, please contact us at +2348077798758 or visit our website. Taking this step could be pivotal in understanding your health and making informed decisions about your future.
Turnaround time for the results is approximately 3 to 4 weeks, and the sample type required can be blood or extracted DNA, or even a single drop of blood on an FTA card. Before the test, a clinical history and a genetic counseling session are recommended to assess family history regarding specific genes linked to cancer.